Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

SELL
$0.91 - $1.69 $187 - $348
-206 Reduced 86.55%
32 $0
Q2 2022

Aug 15, 2022

SELL
$1.28 - $2.4 $6,882 - $12,904
-5,377 Reduced 95.76%
238 $0
Q1 2022

May 12, 2022

BUY
$2.19 - $6.09 $9,598 - $26,692
4,383 Added 355.76%
5,615 $12,000
Q4 2021

Feb 14, 2022

SELL
$5.81 - $14.39 $13,752 - $34,061
-2,367 Reduced 65.77%
1,232 $8,000
Q3 2021

Nov 15, 2021

BUY
$11.55 - $20.3 $36,012 - $63,295
3,118 Added 648.23%
3,599 $50,000
Q2 2021

Aug 16, 2021

BUY
$17.9 - $23.29 $8,609 - $11,202
481 New
481 $10,000
Q3 2020

Nov 16, 2020

SELL
$9.1 - $15.81 $3,640 - $6,324
-400 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$11.29 - $16.0 $4,516 - $6,400
400 New
400 $5,000

Others Institutions Holding GTH

# of Institutions
1
Shares Held
7.5K
Call Options Held
0
Put Options Held
0

About Genetron Holdings Ltd


  • Ticker GTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 90,602,304
  • Description
  • Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. It also provides in-vitro diagn...
More about GTH
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.